Skip To The Main Content
Committee & Speaker Biographies

Committee & Speaker Biographies

2019 PDA Europe Pre-Conference Workshop
Innovative Drug Delivery Systems/Combination Products 

21 October 2019, Gothenburg/Sweden

  • Schoenknecht_Thomas

    Thomas P. Schönknecht, PhD


    Thomas Schoenknecht has over 20 years’ experience in the pharmaceutical industry in various leading roles such as project management, research & development and business development. Before joining LONZA in 2019 as Head of Research and Development of DrugProductServices, Thomas has been with SHL since 2013 as an Executive

    Director of Business Development, responsible for global Business Development, Key Account Management and new Technology Evaluation, Thomas has gained experience in various leading positions in product and business development at Schott Pharmaceutical Packing Division, Amgen Inc California and Gerresheimer’s Pharmaceutical Packing Division.

    Thomas has a Ph.D. in Biophysical Chemistry from the Max-Planck-Society and the University Goettingen, Germany and a Master’s degree in Chemistry from the University Goettingen.

  • Alphons Fakler

    Alphons Fakler

    Alphons is heading the medical device risk management group within Device Development & Commercialization at Novartis Pharma in Basel. He graduated with a state examination in pharmaceutical sciences from Ludwig-Maximilian-University Munich in 1993. Alphons holds a post-graduate degree in applied statistics from ETH Zürich. He joined Novartis in 2012 as a Senior Packaging Expert coming from SCHOTT Pharmaceutical Packaging. There he had served in several development functions at last as Head of Product and Process Development Sterile Products. For more than 20 years, he is working in the development of products and devices for pharmaceutical and biotech applications.
  • Michael Karl Ledinegg

    Michael Karl Ledinegg


    Michael is Senior Manager of Global Development QA External Collaboration at Sandoz.He has a background in Microbiology and Business Administration with over 10 years of experience in the pharmaceutical industry. Michael has held key quality roles in operations and development, including roles as a GxP Auditor, QA Compliance Manager and Global Quality Project Manager.

    Michael has gathered regulatory knowledge having worked with regulatory authorities for years on a European and International level in the area of medicinal products, medical devices and food supplements (cGxP, CFR 21 Part 4, CFR 820, MDD, MDR, SaMD).>/p>